Obesity, diabetes and metabolic medicine
Our Mission
This application provides a curated view of the efficacy and safety of established and emerging drugs in metabolic medicine, with emphasis on obesity and diabetes. The data is freely available, updated daily using AI agents and human evaluation, and allows for meta-analysing the underlying evidence.
The database includes all outcomes reported in publications, abstracts, press-releases and other communications. The underlying data and documents is embedded into knowledge graphs and vector databases, to allow for in-depth analyses and inference. Non-randomized studies are excluded, irrespective of methodology.
This is an academic project. Researchers are welcome to join us to further improve the database.
Team
Araz Rawshani
MD, PhD
Gothenburg, Sweden
Associate Professor and Cardiologist specializing in cardiovascular disease and obesity. With over a decade of dedicated research in diabetes and metabolic disorders.
Visit gocares.seAidin Rawshani
MD, PhD
Gothenburg, Sweden
Associate Professor and Physician with specialized expertise in diabetes and obesity research. Dr. Rawshani has dedicated his research to advancing our understanding of cardiovascular risk and means of mitigating risk.
How to Cite
If you use data from this database in your research, please cite:
Rawshani Araz, Rawshani Aidin; Cardiometabolic Trials Database; https://metdis.org